Logging Multiple Compounds Without Mixing Up the Record

Tracking more than one compound goes wrong in three specific places: names that collapse into shorthand, unit counts that look identical across different concentrations, and entries that lump several injections into one row. Fix all three with distinct vial identities, full spelled-out names, and one entry per compound per administration.

The underlying problem is that a syringe reading tells you volume. Once two vials of different strength are in rotation, volume alone stops identifying the dose.

Ambiguity comes from three sources

Each source has a different signature in a log, and each has a mechanical fix rather than a discipline-based one.

Medication safety guidance on error-prone abbreviations and dose designations exists because condensed notation gets misread in clinical settings where people are trained. A private shorthand invented for speed has none of that scrutiny, and you will be the one misreading it.

Give every vial a distinct identity

A vial is the unit of tracking, and it needs an identity that a dose entry can point at. Compound name alone is not enough, because the same compound can be in two vials at different concentrations, at different ages, with different remaining volumes.

A workable identity has four parts: compound name, a short number or letter, the concentration, and the first-puncture date. Written out, that is "Compound A, vial 3, 2.5 mg/mL, opened Aug 4". Put the same string on a physical label.

Two rules keep this clean. Never reuse a vial number while the old vial still exists, even empty and awaiting disposal. And when a new vial is mixed at a different concentration than its predecessor, treat that as a notable event worth a log note, because it changes the units you will draw.

One entry per compound, always

Each injection gets its own entry. This is a bookkeeping rule with a practical payoff: it preserves the ability to attribute anything you observe to a specific compound at a specific dose.

A combined entry reading "morning doses given" collapses information that cannot be recovered. Two separate entries, each with compound, vial, concentration, volume, milligrams, site, and time, let you later filter to one compound and see its complete timeline.

Order matters less than completeness, but recording the sequence is still useful if you are administering several injections in one session, since it lets you match a local reaction to the right site and the right compound.

The look-alike problem

Similar names cause errors, which is why look-alike and sound-alike naming is a standing concern in medication safety. In a personal protocol the risk is amplified because the vials are often visually identical, from the same supplier, in the same storage container.

Physical differentiation does most of the work:

• Different colored labels per compound, applied at mixing time.
• Separate storage positions, with each compound in a fixed spot.
• Distinct vial numbers that do not overlap between compounds, so "vial 3" is unambiguous.
• Full names on the label, with any distinguishing detail written out rather than abbreviated.
• A quick verbal or mental read-back of the label immediately before drawing.

The read-back step sounds excessive until the first time it catches you reaching for the wrong vial while half awake.

Do not mix compounds in one syringe

Combining two products in one syringe is a compounding decision, not a convenience choice. Compatibility, stability, and sterility all come into play, and compounding standards treat manipulations of sterile preparations as controlled operations for exactly these reasons. That question belongs to a pharmacist.

The recordkeeping argument points the same direction. A combined injection has one site, one time, and two compounds, which means any local reaction cannot be attributed and any change in effect has two candidate causes. Separate injections cost thirty extra seconds and preserve the ability to reason about what happened.

The same logic rules out sharing a syringe or needle between vials. Beyond the sterility issue, carryover between vials contaminates the contents of both and invalidates the concentration you recorded.

Site rotation across compounds

Rotation must be global, not per compound. Tissue responds to the number of punctures it receives, and it makes no distinction based on what was injected.

If you maintain a numbered site map, advance through it for every injection regardless of compound. Two compounds injected in one session take the next two positions in the sequence, not the same position on opposite sides. Recording site per entry is what makes this auditable later, and it is the field most likely to be skipped when there are several injections to get through.

Structure beats freeform

Freeform notes decay. Within a few weeks, typed compound names have three spellings, concentrations appear inconsistently, and the log can no longer be filtered.

What structure means concretely: compound and vial are selectable references rather than text fields, concentration lives on the vial record and is never retyped per dose, milligrams are computed from volume and concentration rather than entered by hand, and the interface can show one compound's timeline at a time as well as a combined view. Vitadel Protocol models compounds and vials as separate records for that reason, so adding a second or third compound does not degrade the log.

What a reviewer should be able to see

Assume a clinician will read this with limited time. They should be able to answer, without asking you anything: which compounds are being taken, at what dose in milligrams, at what interval, from which preparation, and where injections have been going.

That means an export that lists each compound separately, in chronological order, with units and milligrams both present, concentrations stated, sites included, and gaps explicitly marked as skips rather than left as blank space. If your log needs you present to be interpreted, it is not finished.